Yang Huansong, Mu Juwei
Department of Thoracic Surgery, Cancer Hospital of Chinese Academy of Medical Science, Beijing 100000, China.
Zhongguo Fei Ai Za Zhi. 2018 Sep 20;21(9):692-696. doi: 10.3779/j.issn.1009-3419.2018.09.08.
With the change of the spectrum of disease, the incidence and mortality of non-small cell lung cancer (NSCLC) has been high in global scale, since surgical intervention was applied to treat lung cancer, its status is increasing day by day, at present comprehensive treatment leaded by surgery has become the preferred scheme for NSCLC, there are many different kinds of surgical approaches and operation methods of disease, and the new technologies appear constantly, the paper aim to summarize the research progress of different operationmethods and surgical approach. With the development of software and hardware technology and the concept of minimally invasive thoracoscopic surgery was received by more people, minimally invasive thoracoscopic surgery has brought more benifit than traditional thoracotomy for lung cancer patients, minimally invasive thoracoscopic surgery reserve more lung tissue and improve the survival quality of patients due to better pulmonary function, we believe that minimally invasive thoracoscopic surgery can bring more benefits to people with surgical indications and surgical procedure further standardization. .
随着疾病谱的变化,非小细胞肺癌(NSCLC)的发病率和死亡率在全球范围内一直居高不下。自采用手术干预治疗肺癌以来,其地位日益提高。目前,以手术为主导的综合治疗已成为NSCLC的首选方案。针对该疾病有许多不同的手术入路和操作方法,并且新技术不断涌现。本文旨在总结不同手术方法和手术入路的研究进展。随着软硬件技术的发展以及微创胸腔镜手术理念被越来越多的人所接受,微创胸腔镜手术给肺癌患者带来了比传统开胸手术更多的益处。微创胸腔镜手术保留了更多的肺组织,并且由于更好的肺功能而提高了患者的生存质量。我们相信,微创胸腔镜手术能够给有手术指征的患者带来更多益处,并且手术操作将进一步规范化。